Kidney biopsies carried out with a standardized protocol can be performed safely even in patients classified as high-risk, according to Medscape. The outlet published the report on Saturday, October 24, 2026.
The finding speaks to a common concern in nephrology: whether patients with complicating health factors can undergo a biopsy without unacceptable danger. Medscape's report indicates that following a consistent, standardized approach to the procedure addresses that concern.
Medscape did not, in the material available, specify the elements of the protocol, the size of the patient group studied, or the complication rates observed. Those details would be needed to judge how broadly the conclusion applies.
A kidney biopsy involves removing small samples of kidney tissue so they can be examined in a lab, and it is typically used when blood tests and imaging leave questions about kidney disease unanswered. Because the procedure carries bleeding and other risks, clinicians often weigh carefully whether to recommend it for patients whose condition makes complications more likely. A standardized protocol, as described by Medscape, would give care teams a defined set of steps to follow rather than relying on individual judgment alone.
What to watch next: whether professional societies or hospital systems adopt such a protocol, and whether further reporting from Medscape details the patient population and outcomes behind the conclusion.